Doxycycline provides higher odds of microbiological cure compared to azithromycin in cis-men with chlamydia
Doxycycline Shows Higher Cure Rates for Chlamydia in Men
This systematic review and meta-analysis of 1172 patients found that doxycycline (OR = 2.525, 95% CI: 1.329-4.796, p = 0.005) provides a hig…
A review of clinical data suggests doxycycline may be more effective than azithromycin for treating chlamydia infections in men.
Antibiotic resistance mutations drive H. pylori treatment failure across Asia-Pacific region
Antibiotic resistance in H. pylori rising across Asia
This meta-analysis of H. pylori infections in the Asia-Pacific region finds that clarithromycin resistance (19-34%) is driven by A2142G/A214…
H. pylori bacteria in Asia are increasingly resistant to common antibiotics, driven by specific mutations.
Many healthcare students lack knowledge that antibiotics do not speed recovery from colds and flu
Healthcare students often lack clear knowledge on antibiotics and viruses
This meta-analysis of 131 studies from 43 countries found that while 88.7% of healthcare students correctly knew antibiotics treat bacterial…
Many healthcare students are unsure if antibiotics can treat common colds or flu, which may lead to improper use of these important medicine…
Pooled Salmonella prevalence in Ethiopia is 6.7% with significant regional and source variations
Tracking Salmonella Bacteria and Drug Resistance Across Different Areas of Ethiopia
This meta-analysis of 43 datasets from 39 articles identifies a pooled Salmonella prevalence of 6.7% (95% CI: 5.3-8.1%) across human, animal…
New data shows how common Salmonella is in people, animals, and the environment while tracking how well it resists common medicines.
Novel biomarkers and machine learning algorithms facilitate earlier identification and diagnosis of sepsis
New Diagnostic Tools May Help Identify Sepsis More Quickly
This narrative review explores the evolution of sepsis diagnostic strategies from traditional clinical scoring systems to advanced markers l…
Newer biomarkers and machine learning tools are evolving beyond traditional scoring systems to help doctors identify sepsis earlier in patie…
Non-invasive biomarkers offer potential alternatives to invasive kidney biopsy for monitoring renal allograft pathology
New non-invasive tests may replace invasive kidney transplant biopsies
This mini review explores non-invasive biomarkers, including donor-derived cell-free DNA and extracellular vesicles, as tools for monitoring…
Doctors are looking for ways to monitor kidney transplants using blood and urine tests instead of painful, invasive needle biopsies.
FDA Approves Arikayce (amikacin liposome inhalation suspension) for Refractory MAC Lung Disease
FDA approves new drug Arikayce for hard to treat lung infection.
FDA approved Arikayce for treatment of Mycobacterium avium complex (MAC) lung disease in adults with limited or no alternative options, as p…
The FDA approved Arikayce (amikacin liposome inhalation suspension) for adults with a stubborn lung infection called MAC lung disease. It is…
FDA Approves Bicillin C-R (penicillin G benzathine and procaine) for Streptococcal and Pneumococcal Infections
FDA approves new antibiotic Bicillin C-R for certain infections.
The FDA approved Bicillin C-R, a combination of penicillin G benzathine and penicillin G procaine, for moderately severe infections due to s…
The FDA approved Bicillin C-R, a combination penicillin antibiotic, for adults and children with certain bacterial infections like strep thr…
FDA Approves Bicillin L-A (penicillin G benzathine) for Streptococcal Infections and Syphilis
FDA approves Bicillin L-A for certain bacterial infections and prevention.
The FDA approved Bicillin L-A (penicillin G benzathine) for mild-to-moderate upper respiratory streptococcal infections, venereal infections…
The FDA approved Bicillin L-A (penicillin G benzathine) for treating mild-to-moderate infections like strep throat and syphilis, and for pre…
FDA Approves Zevtera (ceftobiprole) for Staphylococcus aureus Bloodstream Infections, ABSSSI, and CABP
FDA approves new antibiotic Zevtera for serious bacterial infections.
The FDA approved Zevtera (ceftobiprole) for adult patients with Staphylococcus aureus bloodstream infections (including right-sided infectiv…
The FDA approved Zevtera (ceftobiprole) to treat Staphylococcus aureus bloodstream infections, including endocarditis, skin infections, and …
Ensitrelvir improves viral clearance and reduces viral RNA in patients with mild-to-moderate COVID-19
Ensitrelvir helps clear the virus in mild to moderate COVID-19
This meta-analysis of 2,890 patients found that Ensitrelvir (125 mg or 250 mg) significantly improved viral clearance and reduced viral RNA …
New data shows that Ensitrelvir can help patients with mild to moderate COVID-19 clear the virus from their systems more quickly.
Intralesional human papillomavirus vaccination significantly increases complete clearance of persistent cutaneous warts
Intralesional HPV Vaccination Shows Promise for Clearing Cutaneous Warts
This systematic review and meta-analysis of 6 studies evaluates intralesional HPV vaccination for patients with chronic or persistent cutane…
A new analysis suggests that injecting the HPV vaccine directly into skin warts may significantly improve clearance rates compared to saline…